Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by ...

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO ...

Altman said that a project like Stargate might not have been possible with "a different president." ...

President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC ...

Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's ...

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

Musk’s criticisms have escalated into legal actions. In February, he filed a lawsuit against OpenAI, accusing it of breaching ...

Sam Altman, CEO of OpenAI ... basically a type of artificial intelligence (AI) that aims to mimic the human brain's cognitive abilities. In a recent interview, Altman said that he is excited ...

Whether you like it or not, artificial intelligence is beginning to reach a point where the world economy and the workforce will be completely changed, according to OpenAI CEO Sam Altman.

Confusion over whether or not OpenAI’s o3-mini has reached the major milestone of artificial general intelligence (AGI) or not deepened on Monday following a post on X by CEO Sam Altman that ...